ClinicalTrials.Veeva

Menu

Combined Afib Ablation and RA Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension

Oregon Health & Science University (OHSU) logo

Oregon Health & Science University (OHSU)

Status

Withdrawn

Conditions

Afib
Hypertension

Treatments

Procedure: Renal Artery denervation

Study type

Interventional

Funder types

Other

Identifiers

NCT01952925
RA-D-9699

Details and patient eligibility

About

The purpose of this study is to perform renal artery denervation at the same time as atrial fibrillation ablation. RA denervation may reduce blood pressure, increase the chances of a successful atrial fibrillation ablation, and decrease the number of medications required to control blood pressure.

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hypertensive patients scheduled for afib ablation
  • Patient taking one or more BP medication

Exclusion criteria

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

Combined afib ablation and RA denervation
Experimental group
Description:
Patients with atrial fibrillation and resistant hypertension will be enrolled and undergo a single procedure consisting of pulmonary vein isolation and renal artery denervation.
Treatment:
Procedure: Renal Artery denervation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems